Zhong-Dong Shi

Company: Frontera Therapeutics

Job title: Executive Director & Head of Vector Research & Development

Seminars:

Unconventional Capsids for Suprachoroidal Injection 3:45 pm

Utilizing cutting-edge techniques to engineer AAV capsids, optimizing tissue specificity and transduction efficiency for targeted delivery in ophthalmic disorders Selecting and designing capsids that enhance suprachoroidal injection, ensuring effective gene delivery while prioritizing safety and scalability Pioneering methods in customizing capsids to precisely target specific cell types or organelles, revolutionizing gene therapy for ophthalmic disordersRead more

day: Day One 11th

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.